<DOC>
	<DOCNO>NCT03025477</DOCNO>
	<brief_summary>CHIMOVIP study determine best therapeutic strategy patient ovarian advanced cancer .</brief_summary>
	<brief_title>Two Therapeutic Strategies First-line Patients With Epithelial Advanced Ovarian Cancer</brief_title>
	<detailed_description>This randomized phase II study , open-label multicentric . After initial intervention ( debulking surgery diagnostic surgery ) patient randomize study accord Completeness cytoreduction ( CC ) score ( CC0 CC &gt; 1 ) .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Histologically confirm advanced ( FIGO stage III IV ) invasive epithelial ovarian cancer , primary peritoneal cancer , fallopiantube cancer . Pleural cytology perform patient pleural effusion . Initial intervention : debulking surgery diagnostic surgery 3 week inclusion Age ≥18 &lt; 75 year old . Eastern Cooperative Oncology Group ( ECOG ) performance status ≤ 2 surgery ( ECOG ≤ 1 Lee score &lt; 6 patient &gt; 70 year old ) . Adequate blood count ( test realize past 14 day inclusion ) : neutrophil &gt; 1500/mm3 , platelet &gt; 150 000/mm3 . Creatinine clearance MDRD ≥ 60 mL/min Registration national health care system ( CMU include ) . Signed date informed consent . FIGO stage IV extraabdominal disease , exception lymph node pleural invasion . Patient receive previous chemotherapy ovarian cancer . Left ventricular ejection fraction &lt; 50 % chemotherapy initiation Other invasive cancer past 5 year ( baso spinocellular cutaneous carcinoma complete resection accept ) Concomitant administration prophylactic phenytoin live attenuate viral vaccine yellow fever vaccine , Patients know hypersensitivity component study drug Patients without motivation capacity respect study requirement constraint Pregnancy breast feeding woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Intraperitoneal</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Completeness cytoreduction score</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Epirubicin</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Cisplatin</keyword>
</DOC>